|
|
Article: Small observational study: fluvoxamine not linked to rise in fetal malformation risk.(News)
- Article from:
- OB GYN News
- Article date:
- May 1, 2004
- Author:
CopyrightCOPYRIGHT 2004 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
MIAMI -- The use of fluvoxamine in pregnancy is not associated with an increased risk of major fetal malformations, according to preliminary results of an ongoing observational study.
Investigators compared the pregnancy outcomes of 46 women taking the selective serotonin reuptake inhibitor to treat depression with those of 46 women taking established nonteratogenic products for the same condition. Anna Sivojelezova reported in a poster presentation at the annual meeting of the American Society for Clinical Pharmacology and Therapeutics.
Fetal survival rates, birth weight, and rates of major malformations did not differ significantly between the two ...